| 摘要 |
<p>The invention relates to use of inhibitors of progression of the cell cycle through the G1/S transition point in the prevention or treatment of Alzheimer's disease. In particular, the invention relates to use of alpha1 adernergic receptor antagonists, in particular doxazosin and its salts or derivatives, for treatment or prevention of Alzheimer's disease.</p> |
